ZETA is a globally operating end-to-end solution provider for the biotech and pharmaceutical industries.
From lab to fab: GMP-compliant scaling
The path of newly developed active substances in the lab into the preclinical phase and in early clinical GxP production, followed by scaling of the manufacturing process to industrial scale, through to market introduction in secure routine operation at the production facility, is a complex and challenging process for the pharma and biotech industry. Along with this entire active substance development and manufacturing process, ZETA offers comprehensive services and offers solutions for the construction, scaling and upgrade of production equipment.
Continuous improvement for process and system optimisation
ZETA provides support after process equipment commissioning through targeted ramp-up, as well as service and maintenance along the entire product lifecycle. True to the principle of continuous improvement, ZETA guides customers during process and system optimisation as well as operator training. ZETA’s aim is to achieve a 100% batch success rate.
Time to market – up to 50% faster with ZETA
As an EPCMV expert, ZETA manages the complexity of large-scale projects — from process plant design and construction to cleanroom planning and technical building services — while actively reducing interface risks. ZETA’s design-build approach accelerates project execution by up to 50%, enabling earlier value creation in customers’ CAPEX projects. In doing so, ZETA contributes to the faster market launch of life-saving active ingredients.
A fully integrated digital value chain
ZETA has established itself as an innovation driver in the pharmaceutical and biotech sectors – particularly through the implementation of a fully integrated digital tool chain, encompassing process simulation, engineering, qualification, and operator management. Process simulation plays a key role by enabling early, data-driven decisions, minimising risks, and significantly increasing efficiency in both planning and operations.
Together for a sustainable future in the pharma and biotech industry
ZETA is also actively taking steps towards a more sustainable future for the entire industry. Holistic decarbonisation strategies that reduce targeted emissions during the biopharmaceutical manufacturing process are integrated with sustainable energy sources for the power supply of the entire infrastructure. Investment scenarios in renewable energy are evaluated using profitability calculations.
ZETA is a globally operating end-to-end solution provider for the biotech and pharmaceutical industries:
- Facility Expertise at ZETA
- Engineering Services
- Automation Solutions
- EPCMV contractor
- Fabrication & Delivery
- Process Simulation
- ZETA’s Digital Value Chain
- Magnetic Mixing Technology
- Inline Conditioning System InFlow
- Sustainable Solutions
